Jul. 12, 2021
NRx Pharmaceuticals and Quantum Leap Announce Treatment of Severely Ill COVID-19 Patients with ZYESAMI (Aviptadil) in the I-SPY COVID Trial
NRx Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative™ have begun treating patients with inhaled ZYESAMI™ (Aviptadil), in the I-SPY COVID Trial (NCT04488081),